Surgepays is trading at $0.26, down 5.12% in pre-market amid weaker risk sentiment.

  • No new company-specific announcement was identified for August 18, 2026.
  • The S&P 500 is down 0.49% and Nasdaq Composite is down 1.24%; recent Q2 results showed 40.7% revenue growth and $1.29 million net income, supporting the August 14 rally rather than this decline.
  • Reliable pre-market volume and activity details were unavailable.